Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Food Scene
Community Directory
Community Service
Restaurant Guide
Rescue Me
Other
Specials
Entertainment Now
Spring Wellness
Home & Garden
Home Improvement
Home & Realty
Horizons
Outdoor Guide
Progress
Women
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
2022 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bioatla Inc
(NQ:
BCAB
)
2.450
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 20, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
9
Open
2.450
Bid (Size)
2.330 (4)
Ask (Size)
3.360 (1)
Prev. Close
2.450
Today's Range
2.450 - 2.450
52wk Range
2.010 - 12.15
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
BioAtla to Announce Fourth Quarter and Full-Year 2022 Financial Results and Provide Business Highlights
March 16, 2023
From
BioAtla, Inc.
Via
Globe NewsWire
BioAtla Announces Change in Executive Leadership
February 27, 2023
From
BioAtla, Inc.
Via
Globe NewsWire
Performance
YTD
-69.68%
-69.68%
1 Month
-25.98%
-25.98%
3 Month
-69.83%
-69.83%
6 Month
-70.59%
-70.59%
1 Year
-55.13%
-55.13%
More News
Read More
BioAtla Announces FDA Clearance of Investigational New Drug Application for BA3182, a CAB-EpCAMxCAB-CD3 Bispecific T-Cell Engager for the Treatment of Advanced Adenocarcinoma
February 23, 2023
From
BioAtla, Inc.
Via
Globe NewsWire
Dow Rises Over 100 Points; Rayonier Advanced Materials Shares Plunge
January 10, 2023
Via
Benzinga
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 10, 2023
Via
Benzinga
Crude Oil Rises Over 1%; Oak Street Health Shares Spike Higher
January 10, 2023
Via
Benzinga
US Stocks Open Higher; Nasdaq Rises 50 Points
January 10, 2023
Via
Benzinga
BioAtla Provides Clinical Program Updates and Upcoming 2023 Milestones
January 10, 2023
From
BioAtla, Inc.
Via
Globe NewsWire
BioAtla to Participate in the 41st Annual J.P. Morgan Healthcare Conference
December 22, 2022
From
BioAtla, Inc.
Via
Globe NewsWire
BioAtla to Participate in the Jefferies London Healthcare Conference
November 08, 2022
From
BioAtla, Inc.
Via
Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via
Benzinga
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
November 07, 2022
Via
Benzinga
Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session
November 04, 2022
Via
Benzinga
Dow Surges 150 Points; US Economy Adds 261,000 Jobs
November 04, 2022
Via
Benzinga
BioAtla Announces $65 Million Underwritten Offering of its Common Stock
November 04, 2022
From
BioAtla, Inc.
Via
Globe NewsWire
Why Starbucks Shares Are Trading Higher; Here Are 43 Stocks Moving Premarket
November 04, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
November 04, 2022
Via
InvestorPlace
BioAtla Reports Third Quarter 2022 Financial Results and Highlights Recent Progress
November 03, 2022
From
BioAtla, Inc.
Via
Globe NewsWire
BioAtla to Announce Third Quarter 2022 Financial Results and Provide Business Highlights on November 3, 2022
October 27, 2022
From
BioAtla, Inc.
Via
Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2022
September 15, 2022
Via
Benzinga
Why MSP Recovery Is Trading Higher By Over 21%, Here Are 61 Stocks Moving In Monday's Mid-Day Session
August 22, 2022
Via
Benzinga
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday
August 18, 2022
Via
Benzinga
Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session
August 17, 2022
Via
Benzinga
Walmart, Gap, Nordstrom And Some Other Big Stocks Recording Gains On Tuesday
August 17, 2022
Via
Benzinga
This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday
August 17, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.